Tejal Somvanshi

Tejal Somvanshi

Ozempic Weight-Loss Craze Hits India's Gray Market: A Global Obesity Drug Sparks Serious Health Risk Concerns as Celebs Drive Demand

Rapid advancement in medication is once again proved through a drug.

Photo Source: Google

Photo Source: Google

This drug was originally intended as a medication for diabetes, but it soon took a turn to become a weight loss sensation throughout the world.

Photo Source: Google

Photo Source: Google

Ozempic is now used as a medicine for obesity and weight loss by a huge number of people from Elon Musk to celebrities in  B- Town.

Photo Source: Google

Photo Source: Google

This drug is mostly covered by the richer echelon of India, and this demand keeps on increasing despite a global shortage of the medicine.

Photo Source: Google

Photo Source: Google

Many medical practitioners have advised against using this drug for weight loss and obesity, it should be consumed only under prescription and supervision of a doctor.

Photo Source: Google

Photo Source: Google

The various side effects of the medicine are listed in detail in its own website, some common side effects include diarrhea, nausea, vomit, abdominal pain and so on.

Photo Source: Google

Photo Source: Google

In addition to common side effects, there can be serious side effects if not taken under proper guidance and thorough check up, the effect can go as far as tumor and cancer.

Photo Source: Google

Photo Source: Google

Not only doctors, but also celebrities like Ali Fazl, Elon Musk, Bella Thorne and so on have spoken up against the use of Ozempic.

Photo Source: Google

Photo Source: Google

In the market, the drug is thriving in the market with increased demand for obesity medication has driven the potential for ozempic to hit $100 billion by 2030.

Photo Source: Google

Photo Source: Google

Research for potential alternatives to Ozempic is underway, however a healthy lifestyle with proper diet and exercise is the most effective way out of obesity without any unhealthy side effects.

Photo Source: Google

Photo Source: Google

Ozempic-Linked Drug Semaglutide Trial Shows 52% Drop in Kidney Disease Markers – Is This the Next Big Breakthrough for CKD Patients?

Next Story

Next Story

Learn more